1365 related articles for article (PubMed ID: 19463580)
1. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
Chen G; Wang Z; Liu XY; Liu FY
Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
[TBL] [Abstract][Full Text] [Related]
2. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
3. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
4. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
5. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of adjuvant radiotherapy on preventing lymph node metastasis after Ivor-lewis esophagectomy in esophageal cancer.
Chen H; Wang Z; Yang Z; Shang B; Liu X; Chen G
Ann Surg Oncol; 2013 Aug; 20(8):2721-6. PubMed ID: 23463093
[TBL] [Abstract][Full Text] [Related]
7. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
Wang Z; Liu XY; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
[TBL] [Abstract][Full Text] [Related]
8. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
9. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
10. [Recurrence pattern and prognosis of esophageal cancer following tumor resection].
Chen J; Sang M; Chen Y
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):293-5. PubMed ID: 10920988
[TBL] [Abstract][Full Text] [Related]
11. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
Chen G; Wang Z; Liu XY; Liu FY
World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905
[TBL] [Abstract][Full Text] [Related]
12. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
14. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic analysis of clinicopathological factors in patients after radical resection of esophageal carcinoma].
Zhu SC; Song CL; Shen WB; Su JW; Li J; Liu ZK
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):281-6. PubMed ID: 22781041
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
17. [Survival analysis of patients with stage II squamous cell carcinoma of the thoracic esophagus after esophagectomy].
Zhang DK; Su XD; Lin P
Ai Zheng; 2008 Feb; 27(2):113-8. PubMed ID: 18279605
[TBL] [Abstract][Full Text] [Related]
18. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
19. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
20. Curative effect comparison between Ivor-Lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma.
Song L; Liu Y; Wang Z; Ren WG; Liu XY
Hepatogastroenterology; 2012 May; 59(115):738-41. PubMed ID: 22024231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]